IL153206A0 - Biosynthetic oncolytic molecules and uses therefor - Google Patents

Biosynthetic oncolytic molecules and uses therefor

Info

Publication number
IL153206A0
IL153206A0 IL15320601A IL15320601A IL153206A0 IL 153206 A0 IL153206 A0 IL 153206A0 IL 15320601 A IL15320601 A IL 15320601A IL 15320601 A IL15320601 A IL 15320601A IL 153206 A0 IL153206 A0 IL 153206A0
Authority
IL
Israel
Prior art keywords
uses therefor
biosynthetic
molecules
oncolytic molecules
biosynthetic oncolytic
Prior art date
Application number
IL15320601A
Original Assignee
Childrens Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Childrens Medical Center filed Critical Childrens Medical Center
Publication of IL153206A0 publication Critical patent/IL153206A0/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00Uses of viruses
    • C12N2799/02Uses of viruses as vector
    • C12N2799/021Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/027Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a retrovirus
IL15320601A 2000-06-13 2001-06-13 Biosynthetic oncolytic molecules and uses therefor IL153206A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21143600P 2000-06-13 2000-06-13
PCT/US2001/019239 WO2001096395A2 (en) 2000-06-13 2001-06-13 Biosynthetic oncolytic molecules and uses therefor

Publications (1)

Publication Number Publication Date
IL153206A0 true IL153206A0 (en) 2003-07-06

Family

ID=22786915

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15320601A IL153206A0 (en) 2000-06-13 2001-06-13 Biosynthetic oncolytic molecules and uses therefor

Country Status (9)

Country Link
EP (1) EP1294756A2 (en)
KR (1) KR20030009522A (en)
CN (1) CN1439020A (en)
AU (1) AU2001266947A1 (en)
BR (1) BR0111628A (en)
CA (1) CA2411346A1 (en)
IL (1) IL153206A0 (en)
WO (1) WO2001096395A2 (en)
ZA (1) ZA200300197B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004013311A2 (en) 2002-08-06 2004-02-12 Diadexus, Inc. Compositions and methods relating to ovarian specific genes and proteins
CA2748937C (en) * 2009-01-28 2016-07-19 Industrial Technology Research Institute Urine and serum biomarkers associated with diabetic nephropathy
KR20110043410A (en) 2010-06-04 2011-04-27 고영산 Intense pulsed light apparatus capable of controlling enegy level with scr
EP2875134A1 (en) * 2012-07-20 2015-05-27 Arla Foods amba Osteopontin peptide fragments for use in suppression or prevention of tumor growth
MX2019013096A (en) 2017-05-04 2019-12-16 Follicum Ab Peptides for treatment of diabetes.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2300194A1 (en) * 1997-08-15 1999-02-25 Children's Medical Center Corporation Osteopontin coated surfaces and methods of use
WO1999066030A1 (en) * 1998-06-15 1999-12-23 Yeda Research And Development Company Ltd. Dap-kinase related protein
US6388054B1 (en) * 1998-08-20 2002-05-14 John M. Stewart Anti-cancer compounds
BR0009767A (en) * 1999-04-15 2002-04-30 Childrens Medical Center Osteopontin-derived inhibitory and chemotactic agents and their uses
WO2000063253A1 (en) * 1999-04-16 2000-10-26 Amgen Inc. Agp-1 fusion protein compositions and methods

Also Published As

Publication number Publication date
WO2001096395A2 (en) 2001-12-20
AU2001266947A1 (en) 2001-12-24
BR0111628A (en) 2004-07-20
EP1294756A2 (en) 2003-03-26
CA2411346A1 (en) 2001-12-20
WO2001096395A3 (en) 2002-05-16
KR20030009522A (en) 2003-01-29
CN1439020A (en) 2003-08-27
ZA200300197B (en) 2004-03-10

Similar Documents

Publication Publication Date Title
AU3662101A (en) Cd40-binding apc-activating molecules
AU2002227280A1 (en) Protein modification and maintenance molecules
AU7296801A (en) Il-17 molecules and uses thereof
AU2001213236A1 (en) Mini-cyclone biocollector and concentrator
MXPA02012749A (en) B7-like molecules and uses thereof.
AU4196801A (en) Chordin-like-2 molecules and uses thereof
AU2002214629A1 (en) Non-metallic bioreactor and uses
AU5720601A (en) Bispecific molecules and uses thereof
IL146364A0 (en) Novel phytochelatin synthases and uses therefor
AU2001286976A1 (en) Novel autoinducer molecules and uses therefor
AU2001291132A1 (en) Lymphoma associated molecules and uses therefor
EP1147213A4 (en) Novel rgs-containing molecules and uses thereof
EP1119253A4 (en) NOVEL Th2-SPECIFIC MOLECULES AND USES THEREOF
AU2001267428A1 (en) Direct detection of individual molecules
AU2001270271A1 (en) Protein modification and maintenance molecules
IL153206A0 (en) Biosynthetic oncolytic molecules and uses therefor
GB0022670D0 (en) Molecules
AUPQ884500A0 (en) Novel therapeutic molecules and uses therefor - III
GB0002625D0 (en) Dendroaspin molecules
AU2001253669A1 (en) Human cadherin molecules and uses therefor
AU7161801A (en) B7-like molecules and uses thereof
GB0011068D0 (en) Molecules
GB0101446D0 (en) Molecules
GB0013106D0 (en) Molecules
AU2001280629A1 (en) Cell cycle proteins and mitosis-associated molecules